Help us improve our website

Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 8 of 8 items.

" " FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury Starting date: September 30, 2020 Posting date:…
AlertHealth professional risk communication | 2020-09-30
" " Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market Starting date: September 16, 2020 Posting date: September 30,…
AlertPublic advisory | 2020-09-30
" " All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns Starting date: September 24, 2020 Type of…
AlertPublic advisory | 2020-09-24
" " Unauthorized health products sold on Steroid Hub Canada website may pose serious health risks
Unauthorized health products sold on Steroid Hub Canada website may pose serious health risks Starting date: September 18, 2020 Type of communication: Advisory Subcategory:…
AlertPublic advisory | 2020-09-18
" " Unauthorized products may pose serious health risks (September 16, 2020: Part 1)
Unauthorized products may pose serious health risks (September 16, 2020: Part 1) Starting date: September 16, 2020 Type of communication: Advisory Subcategory: Drugs, Natural…
AlertPublic advisory | 2020-09-16
" " Unauthorized products may pose serious health risks (September 16, 2020: Part 2)
Unauthorized products may pose serious health risks (September 16, 2020: Part 2) Starting date: September 16, 2020 Type of communication: Advisory Subcategory: Drugs, Natural…
AlertPublic advisory | 2020-09-16
" " Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir Starting date: September 8, 2020 Posting date: September 15…
AlertHealth professional risk communication | 2020-09-15
" " ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury Starting date: September 14, 2020 Posting date: September 14, 2020 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2020-09-14
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.